Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The inducement stock options and RSUs have a grant date and vesting commencement date of May 15, 2020, and were granted as inducements material to the new employees entering into employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
- The inducement stock options and RSUs have a grant date and vesting commencement date of May 15, 2020, and were granted as inducements material to the new employees entering into employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
- The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2017 Long-Term Incentive Plan.
- Arena Pharmaceuticals is uniquely positioned to develop best-in-disease medicines with optimized efficacy and safety for patients globally.
- Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.